Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix ®), a life sciences innovator, manufacturer, and exporter, and ...

New findings from the RECOVER-Adult cohort study show that 25 routine clinical lab tests are not effective in diagnosing postacute sequelae of SARS-CoV-2 infection, echoing results from earlier ...

HAYWARD, Calif.--(BUSINESS WIRE)--The first diagnostic test for long COVID is now available to patients across Australia. The test can help physicians diagnose long COVID by differentiating it from ...

NEW YORK, Aug. 12 (UPI) --Blood and urine tests are ineffective for diagnosing long COVID -- a constellation of long-term symptoms such as chronic pain, brain fog, shortness of breath and intense ...

After running more than 160,000 tests for COVID-19, the UC Santa Cruz Colligan Clinical Diagnostic Laboratory will wind down its support of COVID-19 testing. With widespread COVID-19 testing available ...

In early February 2020, Kirsten St. George and her team at New York state's public health lab received a test developed by the Centers for Disease Control and Prevention to diagnose people infected ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window None of 25 ...

The review also calls for embedding diagnostics within the One Health framework, which integrates human, animal, and ...

Long Covid has long eluded scientists looking for its cause. Not knowing what triggers its persistent and distressing symptoms makes the condition challenging to treat; it’s hard to even say ...

After burning bright during the COVID-19 pandemic, Siemens Healthineers is now planning to shutter a relatively small unit within its larger diagnostics enterprise that had focused on molecular ...